1293 related articles for article (PubMed ID: 19557399)
21. Comparison and optimal use of fixed combinations in the management of COPD.
Mensing M; Aalbers R
Int J Chron Obstruct Pulmon Dis; 2007; 2(2):107-16. PubMed ID: 18044682
[TBL] [Abstract][Full Text] [Related]
22. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
Spencer S; Evans DJ; Karner C; Cates CJ
Cochrane Database Syst Rev; 2011 Oct; (10):CD007033. PubMed ID: 21975759
[TBL] [Abstract][Full Text] [Related]
23. Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Postma DS; Kerstjens HA; ten Hacken NH
Naunyn Schmiedebergs Arch Pharmacol; 2008 Aug; 378(2):203-15. PubMed ID: 18500509
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β
Ferguson GT; Darken P; Ballal S; Siddiqui MK; Singh B; Attri S; Holmgren U; de Nigris E
Adv Ther; 2020 Jun; 37(6):2956-2975. PubMed ID: 32335859
[TBL] [Abstract][Full Text] [Related]
25. Management of asthma and chronic obstructive pulmonary disease with combination inhaled corticosteroids and long-acting β-agonists: a review of comparative effectiveness research.
Mapel DW; Roberts MH
Drugs; 2014 May; 74(7):737-55. PubMed ID: 24797158
[TBL] [Abstract][Full Text] [Related]
26. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
[TBL] [Abstract][Full Text] [Related]
27. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
[TBL] [Abstract][Full Text] [Related]
28. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2011 May; (5):CD003137. PubMed ID: 21563136
[TBL] [Abstract][Full Text] [Related]
29. Long-acting β-agonists in asthma management: what is the current status?
Mysore S; Ruffin RE
Drugs; 2011 Nov; 71(16):2091-7. PubMed ID: 22035511
[TBL] [Abstract][Full Text] [Related]
30. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids.
Barnes PJ
Eur Respir J; 2002 Jan; 19(1):182-91. PubMed ID: 11843317
[TBL] [Abstract][Full Text] [Related]
31. Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children.
Gibson PG; Powell H; Ducharme F
Cochrane Database Syst Rev; 2005 Oct; 2005(4):CD005076. PubMed ID: 16235393
[TBL] [Abstract][Full Text] [Related]
32. Inhaled steroids with and without regular formoterol for asthma: serious adverse events.
Janjua S; Schmidt S; Ferrer M; Cates CJ
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD006924. PubMed ID: 31553802
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD).
Adcock IM; Marwick J; Casolari P; Contoli M; Chung KF; Kirkham P; Papi A; Caramori G
Curr Pharm Des; 2010; 16(32):3554-73. PubMed ID: 20977420
[TBL] [Abstract][Full Text] [Related]
34. A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease.
D'Urzo A; Donohue JF; Kardos P; Miravitlles M; Price D
Expert Opin Pharmacother; 2015; 16(12):1845-60. PubMed ID: 26194213
[TBL] [Abstract][Full Text] [Related]
35. Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessment.
Tervonen T; Martinez FJ; Hanania NA; Heidenreich S; Eudicone JM; Gilbert I
Respir Med; 2021 Jan; 176():106278. PubMed ID: 33387985
[TBL] [Abstract][Full Text] [Related]
36. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
[TBL] [Abstract][Full Text] [Related]
37. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ram FS; Cates CJ; Ducharme FM
Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β
Devillier P; Humbert M; Boye A; Zachgo W; Jacques L; Nunn C; West S; Nicholls A; Antoun Z; Spinu L; Grouin JM
Respir Med; 2018 Aug; 141():111-120. PubMed ID: 30053956
[TBL] [Abstract][Full Text] [Related]
39. Ciclesonide versus other inhaled corticosteroids for chronic asthma in children.
Kramer S; Rottier BL; Scholten RJ; Boluyt N
Cochrane Database Syst Rev; 2013 Feb; (2):CD010352. PubMed ID: 23450613
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular safety of long acting beta agonist-inhaled corticosteroid combination products in adult patients with asthma: a systematic review.
Iftikhar IH; Imtiaz M; Brett AS; Amrol DJ
Lung; 2014 Feb; 192(1):47-54. PubMed ID: 24153452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
